No association of proton pump inhibitor use with fasting or postload glycaemia in patients with cardiovascular disease: A cross-sectional retrospective study

Proton pump inhibitor (PPI) use was reportedly associated with an excess of adverse cardiovascular (CV) events, thus making their systemic effects relevant to public health. PPIs reduce gastric acid secretion, causing increased gastrin release.